DENVER, CO (May 27, 2020) – Redwood Green Corp. (OTCQB:RDGC) announced today its stock has been uplisted to the OTCQB® Venture Market (“OTCQB”) and will commence trading on the OTCQB market immediately.
“This marks a significant milestone for Redwood Green and one that firmly aligns with our company’s vision and values,” said Michael Saxon, CEO of Redwood Green. “Our successful transition to the OTCQB Venture Market provides better access to institutional investors, offers a broader shareholder base and provides increased visibility and transparency.”
In order to qualify for listing on the OTCQB, Redwood Green met or exceeded all of the SEC’s requirements, which include being current on all financial reporting, meeting a minimum bid price over time, following enhanced corporate governance standards and undergoing an annual verification and certification process.
“This is an exciting time for the Redwood Green family of companies,” said Saxon. “Put simply, we are poised for growth.”
About Redwood Green Corp.
Redwood Green seeks to become the leading cannabinoid CPG company with national scale. Our mission is to provide consumers with high-quality, safe and effective cannabinoid products, initially focused on consumer needs in athletic recovery, women’s wellness and personal care. The Redwood Green family of companies started with the acquisition of Good Meds in 2019. Redwood Green maintains the highest of governance standards and is publicly traded in the OTCQB Venture Market at OTCmarkets.com, under the trading symbol RDGC. For additional information visit redwoodgreencorp.com.
This press release is not an offer of securities, or a solicitation for purchase, subscription or sale of securities in the United States of America or in any other jurisdiction in which it would be unlawful to do so.
This message may contain forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, that involve known and unknown risks, uncertainties and other factors, including risk factors identified in the Company’s SEC filings, and which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Risks and uncertainties include, without limitation, changes in the regulatory environment affecting the sale and use of cannabis or hemp products, demand for the Company’s products, internal funding and the financial condition of the Company, product roll-out, competition, our dependence upon our commercial partners, and other commercial matters involving the Company, its products and the markets in which the Company operates as well as general economic conditions. The forward-looking statements in this press release are made only as of the date hereof, and unless otherwise required by applicable securities laws, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Caution Regarding Cannabis Operations in the United States
Investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States. Marijuana, as defined in the U.S. Controlled Substances Act, remains a Schedule I drug under the respective act, making it illegal under federal law in the U.S. to, among other things, cultivate, distribute or possess cannabis. Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the U.S. may form the basis for prosecution under applicable U.S. federal money laundering legislation. Please carefully review the Company’s SEC filings with respect to related risk factors.